Skip to Main Content

Las cartas sobre el reembolso del MLR se enviaron por correo el 30 de septiembre. Revise su correo antes del 15 de octubre para obtener más información. Obtenga más información.

Las cartas sobre el reembolso del MLR se enviaron por correo el 30 de septiembre. Revise su correo antes del 15 de octubre para obtener más información. Obtenga más información.

News

Effective September 15, 2025: Clinical Policies

Fecha: 16/07/25

Superior HealthPlan has updated certain clinical policies to ensure medical necessity review criteria is current and appropriate for members and the scope of services provided. As a result the following policies are effective on September 15, 2025, at 12:00AM.

POLICY

APPLICABLE PRODUCTS

NEW POLICY OVERVIEW OR UPDATED POLICY REVISIONS

Allogeneic Hematopoietic Progenitor Cell Therapy

(CP.MP.249)

Ambetter

Policy updates include:

  • Removed Omisirge specific language from title of policy due to expanding policy
  • Updated Description of policy to include RegeneCyte and updated title in the Note referencing the Medicare version of policy
  • Added Criteria II. to include medically necessary criteria for RegeneCyte
  • Background updated to include RegeneCyte information to align with updated criteria

Fecal Incontinence Treatments

(CP.MP.137)

Medicaid (STAR, STAR Health, STAR Kids, STAR+PLUS), CHIP, and Ambetter

Policy updates include:

  • Added criteria I.B.1.d. Member/enrollee demonstrates the ability to operate the device or has a supportive caregiver who could otherwise provide assistance
  • Removed I.B.1.e.iii. Inadequate response to test stimulation or inability to operate the device
  • Removed I.B.3.d. Absence of any physical or mental illness that would increase surgical risk
  • Removed previous criteria I.B.2. for sphincteroplasty
  • Added CPT 44320 and HCPCS C1767, C1778 to coding tables

Reduction Mammoplasty and Gynecomastia Surgery

(CP.MP.51)

Medicaid (STAR, STAR Health, STAR Kids, STAR+PLUS), CHIP, and Ambetter

Policy updates include:

  • Added clarifying language to Criteria I.A
  • Removed “persistent” and “for at least one year” in Criteria I.A.3
  • Added clarifying language to Criteria I.A.3.c. regarding breast pain
  • Added clarifying language regarding inframammary folds in Criteria I.A.3.g
  • Removed criteria II.A.4. requiring adult testicular size to be attained

Skin and Soft Tissue Substitutes for Chronic Wounds

(CP.MP.185)

Medicaid (STAR, STAR Health, STAR Kids, STAR+PLUS), CHIP, and Ambetter

Policy updates include:

  • Added the following codes to the “HCPCS codes that do not support medical necessity criteria” table: A2026, A2027, A2028, A2029, C8002, Q4280, Q4311, Q4312, Q4313, Q4314, Q4315, Q4316, Q4317, Q4318, Q4319, Q4320, Q4321, Q4322, Q4323, Q4324, Q4325, Q4326, Q4327, Q4328, Q4329, Q4330, Q4331, Q4332, Q4333, Q4334, Q4335, Q4336, Q4337, Q4338, Q4339, Q4340, Q4341, Q4342, Q4343, Q4344, Q4345, Q4346, Q4347, Q4348, Q4349, Q4350, Q4351, Q4352, Q4353, Q4368, Q4369, Q4370, Q4371, Q4372, Q4373, Q4375, Q4376, Q4377, Q4378, Q4379, Q4380, Q4382

To review all policies, please visit Superior’s Clinical, Payment & Pharmacy Policies webpage.

Prior to updates, Medical Clinical policies are reviewed and approved by the Utilization Management Committee.

For questions or additional information, contact Superior’s Prior Authorization department at 1-800-218-7508.